Predicting in vitro drug sensitivity using Random Forests

被引:123
作者
Riddick, Gregory [1 ]
Song, Hua [1 ]
Ahn, Susie [1 ]
Walling, Jennifer [1 ]
Borges-Rivera, Diego [2 ]
Zhang, Wei [1 ]
Fine, Howard A. [1 ]
机构
[1] NCI, Neurooncol Branch, NINDS, NIH, Bethesda, MD 20892 USA
[2] Carnegie Mellon Univ, Pittsburgh, PA 15213 USA
基金
美国国家卫生研究院;
关键词
GENE-EXPRESSION; CELL-LINES; PROFILES;
D O I
10.1093/bioinformatics/btq628
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Motivation: Panels of cell lines such as the NCI-60 have long been used to test drug candidates for their ability to inhibit proliferation. Predictive models of in vitro drug sensitivity have previously been constructed using gene expression signatures generated from gene expression microarrays. These statistical models allow the prediction of drug response for cell lines not in the original NCI-60. We improve on existing techniques by developing a novel multistep algorithm that builds regression models of drug response using Random Forest, an ensemble approach based on classification and regression trees (CART). Results: This method proved successful in predicting drug response for both a panel of 19 Breast Cancer and 7 Glioma cell lines, outperformed other methods based on differential gene expression, and has general utility for any application that seeks to relate gene expression data to a continuous output variable. Implementation: Software was written in the R language and will be available together with associated gene expression and drug response data as the package ivDrug at http://r-forge.r-project.org.
引用
收藏
页码:220 / 224
页数:5
相关论文
共 13 条
[1]   Random forests [J].
Breiman, L .
MACHINE LEARNING, 2001, 45 (01) :5-32
[2]   Anticancer medicines in development: assessment of bioactivity profiles within the National Cancer Institute anticancer screening data [J].
Covell, David G. ;
Huang, Ruili ;
Wallqvist, Anders .
MOLECULAR CANCER THERAPEUTICS, 2007, 6 (08) :2261-2270
[3]   Gene selection and classification of microarray data using random forest -: art. no. 3 [J].
Díaz-Uriarte, R ;
de Andrés, SA .
BMC BIOINFORMATICS, 2006, 7 (1)
[4]   A modular approach for integrative analysis of large-scale gene-expression and drug-response data [J].
Kutalik, Zoltan ;
Beckmann, Jacques S. ;
Bergmann, Sven .
NATURE BIOTECHNOLOGY, 2008, 26 (05) :531-539
[5]   A strategy for predicting the chemosensitivity of human cancers and its application to drug discovery [J].
Lee, Jae K. ;
Havaleshko, Dmytro M. ;
Cho, HyungJun ;
Weinstein, John N. ;
Kaldjian, Eric P. ;
Karpovich, John ;
Grimshaw, Andrew ;
Theodorescu, Dan .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (32) :13086-13091
[6]   Genomic changes and gene expression profiles reveal that established glioma cell lines are poorly representative of primary human gliomas [J].
Li, Aiguo ;
Walling, Jennifer ;
Kotliarov, Yuri ;
Center, Angela ;
Steed, Mary Ellen ;
Ahn, Susie J. ;
Rosenblum, Mark ;
Mikkelsen, Tom ;
Zenklusen, Jean Claude ;
Fine, Howard A. .
MOLECULAR CANCER RESEARCH, 2008, 6 (01) :21-30
[7]   Utilization of Genomic Signatures to Identify Phenotype-Specific Drugs [J].
Mori, Seiichi ;
Chang, Jeffrey T. ;
Andrechek, Eran R. ;
Potti, Anil ;
Nevins, Joseph R. .
PLOS ONE, 2009, 4 (08)
[8]   DISPLAY AND ANALYSIS OF PATTERNS OF DIFFERENTIAL ACTIVITY OF DRUGS AGAINST HUMAN-TUMOR CELL-LINES - DEVELOPMENT OF MEAN GRAPH AND COMPARE ALGORITHM [J].
PAULL, KD ;
SHOEMAKER, RH ;
HODES, L ;
MONKS, A ;
SCUDIERO, DA ;
RUBINSTEIN, L ;
PLOWMAN, J ;
BOYD, MR .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (14) :1088-1092
[9]   RETRACTED: Genomic signatures to guide the use of chemotherapeutics (Retracted article. See vol. 17, pg. 135, 2011) [J].
Potti, Anil ;
Dressman, Holly K. ;
Bild, Andrea ;
Riedel, Richard F. ;
Chan, Gina ;
Sayer, Robyn ;
Cragun, Janiel ;
Cottrill, Hope ;
Kelley, Michael J. ;
Petersen, Rebecca ;
Harpole, David ;
Marks, Jeffrey ;
Berchuck, Andrew ;
Ginsburg, Geoffrey S. ;
Febbo, Phillip ;
Lancaster, Johnathan ;
Nevins, Joseph R. .
NATURE MEDICINE, 2006, 12 (11) :1294-1300
[10]   The NCI60 human tumour cell line anticancer drug screen [J].
Shoemaker, Robert H. .
NATURE REVIEWS CANCER, 2006, 6 (10) :813-823